Chemoinformaics analysis of (3S)-2,2,3-trimethyl-3-(4-methylphenyl)cyclopentan-1-one
| Molecular Weight | 216.324 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 12 |
| Exact Molecular Weight | 216.151 | nRing | 2 |
| Solubility: LogS | -3.419 | nHRing | 0 |
| Solubility: LogP | 3.415 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 39.1879 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.7 |
| Synth | 2.893 |
| Natural Product Likeliness | 1.301 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.845 |
| Pgp-sub | 0.01 |
| HIA | 0.009 |
| CACO-2 | -4.689 |
| MDCK | 0.0000207 |
| BBB | 0.283 |
| PPB | 0.901109 |
| VDSS | 1.01 |
| FU | 0.107962 |
| CYP1A2-inh | 0.657 |
| CYP1A2-sub | 0.92 |
| CYP2c19-inh | 0.843 |
| CYP2c19-sub | 0.95 |
| CYP2c9-inh | 0.439 |
| CYP2c9-sub | 0.834 |
| CYP2d6-inh | 0.076 |
| CYP2d6-sub | 0.684 |
| CYP3a4-inh | 0.507 |
| CYP3a4-sub | 0.745 |
| CL | 13.697 |
| T12 | 0.462 |
| hERG | 0.04 |
| Ames | 0.016 |
| ROA | 0.515 |
| SkinSen | 0.202 |
| Carcinogencity | 0.475 |
| EI | 0.862 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.128 |
| Antiviral | Yes |
| Prediction | 0.784483 |